Literature DB >> 22789553

Moyamoya disease in which pentazocine treatment caused cerebral infarction.

Yoshinori Matsuoka1, Makoto Hashizume.   

Abstract

A 37-year-old man was admitted to hospital for treatment of perineum damage and haematoma in the scrotum. His consciousness deteriorated after two intramuscular injections of pentazocine 15 mg. Faint low signals in the left putamin to frontal island and frontal lobe and obnubilation of the corticomedullary junction were apparent on head CT, which led to suspicion of cerebral infarction. MR angiography showed bilateral obstruction of the middle cerebral artery and moyamoya disease was diagnosed. Treatment with edaravone, argatroban and heparin was ineffective for opening the middle cerebral artery and serious after effects occurred. This case suggests that cerebrovascular accident should be suspected in a young patient with disturbance of consciousness but stable breathing and circulation, particularly if previous drug treatment has affected brain circulation. Moyamoya disease should be suspected based on medical or family history. In such a case, MR angiography is required for early diagnosis to facilitate treatment by re-establishment of blood circulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22789553      PMCID: PMC3027790          DOI: 10.1136/bcr.03.2010.2846

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Clinical features and outcome in North American adults with moyamoya phenomenon.

Authors:  Christopher L Hallemeier; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Ralph G Dacey; Colin P Derdeyn
Journal:  Stroke       Date:  2006-04-27       Impact factor: 7.914

2.  A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease.

Authors:  D H Han; O K Kwon; B J Byun; B Y Choi; C W Choi; J U Choi; S G Choi; J O Doh; J W Han; S Jung; S D Kang; D J Kim; H I Kim; H D Kim; M C Kim; S C Kim; S C Kim; Y Kim; B D Kwun; B G Lee; Y J Lim; J G Moon; H S Park; M S Shin; J H Song; J S Suk; M B Yim
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

3.  [Buprenorphine and pentazocine in acute myocardial infarct. Study for a differential use].

Authors:  C A Cecchi; G Bacci; P L Battelli; D Multinu; A C Signorini; M Scheggi; F Marchi
Journal:  G Ital Cardiol       Date:  1988-09

4.  Incidence and clinical features of disease progression in adult moyamoya disease.

Authors:  Satoshi Kuroda; Tatsuya Ishikawa; Kiyohiro Houkin; Rina Nanba; Masaaki Hokari; Yoshinobu Iwasaki
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

5.  Multiple burr-hole operation for adult moyamoya disease.

Authors:  T Kawaguchi; S Fujita; K Hosoda; Y Shose; S Hamano; M Iwakura; N Tamaki
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

6.  A clinical comparison of definite moyamoya disease between South Korea and Japan.

Authors:  K Ikezaki; D H Han; T Kawano; N Kinukawa; M Fukui
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

Review 7.  Familial moyamoya disease in Caucasians.

Authors:  N Shetty-Alva; S Alva
Journal:  Pediatr Neurol       Date:  2000-11       Impact factor: 3.372

8.  Pentazocine (Talwin) intoxication: report of 57 cases.

Authors:  K R Challoner; M M McCarron; E J Newton
Journal:  J Emerg Med       Date:  1990 Jan-Feb       Impact factor: 1.484

9.  [Follow-up study on the relationship between age at onset of illness and outcome in patients with moyamoya disease].

Authors:  K Moritake; H Handa; Y Yonekawa; W Taki; T Okuno
Journal:  No Shinkei Geka       Date:  1986-07

10.  Diagnosis of moyamoya disease with magnetic resonance angiography.

Authors:  K Houkin; T Aoki; A Takahashi; H Abe
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.